These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1477436)

  • 41. Persistent myocardial ischemia after termination of dipyridamole-induced ventricular tachycardia by intravenous aminophylline: scintigraphic demonstration.
    Chang WT; Lin LC; Yen RF; Huang PJ
    J Formos Med Assoc; 2000 Mar; 99(3):264-6. PubMed ID: 10820963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy.
    Belardinelli R; Belardinelli L; Shryock JC
    Eur Heart J; 2001 Jul; 22(14):1205-13. PubMed ID: 11440493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups.
    Fridrich L
    Eur J Nucl Med; 1989; 15(2):81-6. PubMed ID: 2920742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dipyridamole 201Tl scintigraphy in the evaluation of prognosis after myocardial infarction.
    Okada RD; Glover DK; Leppo JA
    Circulation; 1991 Sep; 84(3 Suppl):I132-9. PubMed ID: 1884479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-body imaging of thallium-201 after six different stress regimens.
    Pennell DJ; Ell PJ
    J Nucl Med; 1994 Mar; 35(3):425-8. PubMed ID: 8113888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of intravenous dipyridamole and adenosine Tc-99m MIBI myocardial imaging for detection of coronary artery disease.
    Yang CC; Jong SB; Chen UW; Lee BF; Wu CN
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Feb; 10(2):68-76. PubMed ID: 8176773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenosine-echocardiography for the detection of coronary artery disease.
    Takeishi Y; Chiba J; Abe S; Ikeda K; Tomoike H
    J Cardiol; 1994; 24(1):1-7. PubMed ID: 8158526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thallium-201 myocardial imaging during coronary vasodilation induced by oral dipyridamole.
    Gould KL; Sorenson SG; Albro P; Caldwell JH; Chaudhuri T; Hamilton GW
    J Nucl Med; 1986 Jan; 27(1):31-6. PubMed ID: 3941362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrinsic washout rates of thallium-201 in normal and ischemic myocardium after dipyridamole-induced vasodilation.
    Beller GA; Holzgrefe HH; Watson DD
    Circulation; 1985 Feb; 71(2):378-86. PubMed ID: 3965178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of pharmacological (intravenous dipyridamole) stress for Thallium-201 perfusion imaging in patients with coronary artery disease unable to exercise.
    Zaman M; Hashmi R; Niaz K; Ahmad A; Kamal S
    J Pak Med Assoc; 1994 Oct; 44(10):237-9. PubMed ID: 7815687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disposition of oral dipyridamole in patients undergoing thallium 201 myocardial imaging.
    Stringer KA; Branconi JM; Abadier R; Wilton JH; Royal SH
    Pharmacotherapy; 1992; 12(2):83-7. PubMed ID: 1570231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging.
    Villegas BJ; Hendel RC; Dahlberg ST; McSherry BA; Leppo JA
    Am Heart J; 1993 Jul; 126(1):103-7. PubMed ID: 8322650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term prognostic value of a normal dipyridamole thallium-201 perfusion scan.
    Gal RA; Gunasekera J; Massardo T; Shalev Y; Port SC
    Clin Cardiol; 1991 Dec; 14(12):971-4. PubMed ID: 1841022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial perfusion imaging with thallium-201.
    Beller GA
    J Nucl Med; 1994 Apr; 35(4):674-80. PubMed ID: 8151393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease.
    Varma SK; Watson DD; Beller GA
    Am J Cardiol; 1989 Oct; 64(14):871-7. PubMed ID: 2801554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT.
    Chin BB; Moshin J; Bouchard M; Berlin JA; Araujo LI; Alavi A
    J Nucl Med; 1996 May; 37(5):723-9. PubMed ID: 8965134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dipyridamole thallium-201 myocardial imaging. Complications associated with oral and intravenous routes of administration.
    Aksut SV; Port S; Collier BD; Hoffmann RG; Massardo T; Hellman RS; Isitman AT; Carnell A; Devich EC
    Clin Nucl Med; 1988 Nov; 13(11):786-8. PubMed ID: 3233865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men.
    Kong BA; Shaw L; Miller DD; Chaitman BR
    Am J Cardiol; 1992 Jul; 70(2):168-73. PubMed ID: 1626502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging.
    Shaffer J; Simbartl L; Render ML; Snow E; Chaney C; Nishiyama H; Rauf GC; Wexler LF
    Am Heart J; 1998 Aug; 136(2):307-13. PubMed ID: 9704695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.